Provider
QP101-22 Update for New to Market Medical Drugs: Lecanemab and Lifileucel
Program effective Date: Dec 16, 2022
Program effective Date: Dec 16, 2022
Program effective Date: Dec 28, 2022
Program effective Date: Dec 28, 2022
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2025
Quantity Limit
Program effective Date: Feb 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Jul 01, 2024
Prior Authorization
Program effective Date: Feb 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Nov 01, 2024